Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,324 papers from all fields of science
Search
Sign In
Create Free Account
Circumscribed Storiform Collagenoma
A benign skin tumor characterized as a small, dome-shaped dermal nodule composed of fibroblasts in a dense collagenous background with storiform…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Integumentary system
Skin
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Pacinian collagenoma: A distinct form of sclerotic fibroma
Lucia Krivošíková
,
P. Janega
,
J. Babala
,
P. Babál
Journal of cutaneous pathology
2020
Corpus ID: 204544601
Sclerotic fibroma (storiform collagenoma) is a rare benign skin tumor. A solitary tumor, as well as multifocal lesions, are found…
Expand
2013
2013
Colagenoma plantar solitario cerebriforme
C. Bianchi
,
O. Sanguinetti
,
C. Civitillo
,
B. Perisse
2013
Corpus ID: 164150328
The term Collagenoma defines a type of connective tissue nevus (NTC) consisting predominantly of dermal collagen accumulation of…
Expand
Review
2012
Review
2012
Colonic ganglioneuromatous polyposis and metastatic adenocarcinoma in the setting of Cowden syndrome: a case report and literature review.
Joshua W Trufant
,
L. Greene
,
D. Cook
,
W. Mckinnon
,
M. Greenblatt
,
M. Bosenberg
Human Pathology
2012
Corpus ID: 46079211
1999
1999
Storiform collagenoma of the nail.
A. Tosti
,
N. Cameli
,
A. M. Peluso
,
P. Fanti
,
A. Peserico
Cutis (New York, N.Y.)
1999
Corpus ID: 44842321
The term circumscribed storiform collagenoma was coined by Maize et al in 1989 to describe four dermal fibromas with pathologic…
Expand
1985
1985
Pigmented storiform neurofibromaにおける腫瘍細胞dermal melanocyteの光顕的・電顕的観察
及川 修
,
神保 孝一
1985
Corpus ID: 175297300
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE